Competitive PressureAs more companies independently report positive data from RPE transplants, the growing body of evidence further reinforces confidence in this treatment paradigm, increasing competitive pressure.
Regulatory ChallengesThe durability of vision gains over three years, despite dry AMD being a degenerative and irreversible disease, suggests a lasting treatment effect, which could serve as a significant catalyst for Lineage, yet regulatory challenges may still arise.